APO Research
Talk to an analyst

APO RESEARCH · REPORT

Typhoid Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Typhoid Vaccine Market Analysis and Forecast 2026-2032

26 December 2025190 pages

Choose your research edition.

Industry ResearchTyphoid Vaccine Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Typhoid Vaccine Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Typhoid Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Typhoid Vaccine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Typhoid Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Typhoid Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Typhoid Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Typhoid Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Typhoid Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Typhoid Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Typhoid Vaccine include Actiza Pharmaceutical, Bharat Biotec, Merit Pharmaceuticals, PaxVax, GlaxoSmithKline, Merck and Sanofi, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Typhoid Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Typhoid Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Typhoid Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Typhoid Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Typhoid Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Typhoid Vaccine sales, projected growth trends, production technology, application and end-user industry.

Typhoid Vaccine Segment by Company

Actiza Pharmaceutical

Bharat Biotec

Merit Pharmaceuticals

PaxVax

GlaxoSmithKline

Merck

Sanofi

Typhoid Vaccine Segment by Type

Oral Type Typhoid Vaccine

Injection Type Typhoid Vaccine

Typhoid Vaccine Segment by Application

Pharmaceutical & Biotechnology Companies

Hospital

Research & Academic Laboratories

Others

Typhoid Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Typhoid Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Typhoid Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Typhoid Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Typhoid Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Typhoid Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Typhoid Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Typhoid Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Type Typhoid Vaccine Major Manufacturers Table 3. Injection Type Typhoid Vaccine Major Manufacturers Table 4. Global Typhoid Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Pharmaceutical & Biotechnology Companies Major Manufacturers Table 6. Hospital Major Manufacturers Table 7. Research & Academic Laboratories Major Manufacturers Table 8. Others Major Manufacturers Table 9. Typhoid Vaccine Industry Trends Table 10. Typhoid Vaccine Industry Drivers Table 11. Typhoid Vaccine Industry Opportunities and Challenges Table 12. Typhoid Vaccine Industry Restraints Table 13. Global Typhoid Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Typhoid Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Typhoid Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Typhoid Vaccine Revenue Market Share by Region (2021-2026) Table 17. Global Typhoid Vaccine Revenue Market Share by Region (2027-2032) Table 18. Global Typhoid Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Typhoid Vaccine Sales by Region (2021-2026) & (K Units) Table 20. Global Typhoid Vaccine Sales by Region (2027-2032) & (K Units) Table 21. Global Typhoid Vaccine Sales Market Share by Region (2021-2026) Table 22. Global Typhoid Vaccine Sales Market Share by Region (2027-2032) Table 23. Global Typhoid Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Typhoid Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Typhoid Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Typhoid Vaccine Sales Market Share by Manufacturers (2021-2026) Table 27. Global Typhoid Vaccine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Typhoid Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Typhoid Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Typhoid Vaccine Manufacturers, Product Type & Application Table 31. Global Typhoid Vaccine Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Typhoid Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Typhoid Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Typhoid Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Typhoid Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Typhoid Vaccine Revenue Market Share by Type (2021-2026) Table 38. Global Typhoid Vaccine Revenue Market Share by Type (2027-2032) Table 39. Global Typhoid Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Typhoid Vaccine Sales by Type (2021-2026) & (K Units) Table 41. Global Typhoid Vaccine Sales by Type (2027-2032) & (K Units) Table 42. Global Typhoid Vaccine Sales Market Share by Type (2021-2026) Table 43. Global Typhoid Vaccine Sales Market Share by Type (2027-2032) Table 44. Global Typhoid Vaccine Price by Type (2021-2026) & (US$/Unit) Table 45. Global Typhoid Vaccine Price by Type (2027-2032) & (US$/Unit) Table 46. Global Typhoid Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Typhoid Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Typhoid Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Typhoid Vaccine Revenue Market Share by Application (2021-2026) Table 50. Global Typhoid Vaccine Revenue Market Share by Application (2027-2032) Table 51. Global Typhoid Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Typhoid Vaccine Sales by Application (2021-2026) & (K Units) Table 53. Global Typhoid Vaccine Sales by Application (2027-2032) & (K Units) Table 54. Global Typhoid Vaccine Sales Market Share by Application (2021-2026) Table 55. Global Typhoid Vaccine Sales Market Share by Application (2027-2032) Table 56. Global Typhoid Vaccine Price by Application (2021-2026) & (US$/Unit) Table 57. Global Typhoid Vaccine Price by Application (2027-2032) & (US$/Unit) Table 58. Actiza Pharmaceutical Company Information Table 59. Actiza Pharmaceutical Business Overview Table 60. Actiza Pharmaceutical Typhoid Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Actiza Pharmaceutical Typhoid Vaccine Product Portfolio Table 62. Actiza Pharmaceutical Recent Development Table 63. Bharat Biotec Company Information Table 64. Bharat Biotec Business Overview Table 65. Bharat Biotec Typhoid Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Bharat Biotec Typhoid Vaccine Product Portfolio Table 67. Bharat Biotec Recent Development Table 68. Merit Pharmaceuticals Company Information Table 69. Merit Pharmaceuticals Business Overview Table 70. Merit Pharmaceuticals Typhoid Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Merit Pharmaceuticals Typhoid Vaccine Product Portfolio Table 72. Merit Pharmaceuticals Recent Development Table 73. PaxVax Company Information Table 74. PaxVax Business Overview Table 75. PaxVax Typhoid Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. PaxVax Typhoid Vaccine Product Portfolio Table 77. PaxVax Recent Development Table 78. GlaxoSmithKline Company Information Table 79. GlaxoSmithKline Business Overview Table 80. GlaxoSmithKline Typhoid Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. GlaxoSmithKline Typhoid Vaccine Product Portfolio Table 82. GlaxoSmithKline Recent Development Table 83. Merck Company Information Table 84. Merck Business Overview Table 85. Merck Typhoid Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Merck Typhoid Vaccine Product Portfolio Table 87. Merck Recent Development Table 88. Sanofi Company Information Table 89. Sanofi Business Overview Table 90. Sanofi Typhoid Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Sanofi Typhoid Vaccine Product Portfolio Table 92. Sanofi Recent Development Table 93. North America Typhoid Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 94. North America Typhoid Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 95. North America Typhoid Vaccine Sales by Type (2021-2026) & (K Units) Table 96. North America Typhoid Vaccine Sales by Type (2027-2032) & (K Units) Table 97. North America Typhoid Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 98. North America Typhoid Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 99. North America Typhoid Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 100. North America Typhoid Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 101. North America Typhoid Vaccine Sales by Application (2021-2026) & (K Units) Table 102. North America Typhoid Vaccine Sales by Application (2027-2032) & (K Units) Table 103. North America Typhoid Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 104. North America Typhoid Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 105. North America Typhoid Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America Typhoid Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 107. North America Typhoid Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 108. North America Typhoid Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 109. North America Typhoid Vaccine Sales by Country (2021-2026) & (K Units) Table 110. North America Typhoid Vaccine Sales by Country (2027-2032) & (K Units) Table 111. North America Typhoid Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 112. North America Typhoid Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 113. United States Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 114. Canada Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 115. Mexico Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 116. Europe Typhoid Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 117. Europe Typhoid Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 118. Europe Typhoid Vaccine Sales by Type (2021-2026) & (K Units) Table 119. Europe Typhoid Vaccine Sales by Type (2027-2032) & (K Units) Table 120. Europe Typhoid Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 121. Europe Typhoid Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 122. Europe Typhoid Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 123. Europe Typhoid Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 124. Europe Typhoid Vaccine Sales by Application (2021-2026) & (K Units) Table 125. Europe Typhoid Vaccine Sales by Application (2027-2032) & (K Units) Table 126. Europe Typhoid Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 127. Europe Typhoid Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 128. Europe Typhoid Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Europe Typhoid Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 130. Europe Typhoid Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 131. Europe Typhoid Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 132. Europe Typhoid Vaccine Sales by Country (2021-2026) & (K Units) Table 133. Europe Typhoid Vaccine Sales by Country (2027-2032) & (K Units) Table 134. Europe Typhoid Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 135. Europe Typhoid Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 136. Germany Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 137. France Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 138. U.K. Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 139. Italy Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 140. Russia Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 141. Spain Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 142. Netherlands Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 143. Switzerland Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 144. Sweden Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 145. Poland Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 146. China Typhoid Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 147. China Typhoid Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 148. China Typhoid Vaccine Sales by Type (2021-2026) & (K Units) Table 149. China Typhoid Vaccine Sales by Type (2027-2032) & (K Units) Table 150. China Typhoid Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 151. China Typhoid Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 152. China Typhoid Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 153. China Typhoid Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 154. China Typhoid Vaccine Sales by Application (2021-2026) & (K Units) Table 155. China Typhoid Vaccine Sales by Application (2027-2032) & (K Units) Table 156. China Typhoid Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 157. China Typhoid Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 158. Asia Typhoid Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 159. Asia Typhoid Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 160. Asia Typhoid Vaccine Sales by Type (2021-2026) & (K Units) Table 161. Asia Typhoid Vaccine Sales by Type (2027-2032) & (K Units) Table 162. Asia Typhoid Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 163. Asia Typhoid Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 164. Asia Typhoid Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 165. Asia Typhoid Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 166. Asia Typhoid Vaccine Sales by Application (2021-2026) & (K Units) Table 167. Asia Typhoid Vaccine Sales by Application (2027-2032) & (K Units) Table 168. Asia Typhoid Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 169. Asia Typhoid Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 170. Asia Typhoid Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. Asia Typhoid Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. Asia Typhoid Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. Asia Typhoid Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 174. Asia Typhoid Vaccine Sales by Country (2021-2026) & (K Units) Table 175. Asia Typhoid Vaccine Sales by Country (2027-2032) & (K Units) Table 176. Asia Typhoid Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 177. Asia Typhoid Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 178. Japan Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 179. South Korea Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 180. India Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 181. Australia Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 182. Taiwan Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 183. Southeast Asia Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 184. SAMEA Typhoid Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 185. SAMEA Typhoid Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 186. SAMEA Typhoid Vaccine Sales by Type (2021-2026) & (K Units) Table 187. SAMEA Typhoid Vaccine Sales by Type (2027-2032) & (K Units) Table 188. SAMEA Typhoid Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 189. SAMEA Typhoid Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 190. SAMEA Typhoid Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 191. SAMEA Typhoid Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 192. SAMEA Typhoid Vaccine Sales by Application (2021-2026) & (K Units) Table 193. SAMEA Typhoid Vaccine Sales by Application (2027-2032) & (K Units) Table 194. SAMEA Typhoid Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 195. SAMEA Typhoid Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 196. SAMEA Typhoid Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 197. SAMEA Typhoid Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 198. SAMEA Typhoid Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 199. SAMEA Typhoid Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 200. SAMEA Typhoid Vaccine Sales by Country (2021-2026) & (K Units) Table 201. SAMEA Typhoid Vaccine Sales by Country (2027-2032) & (K Units) Table 202. SAMEA Typhoid Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 203. SAMEA Typhoid Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 204. Brazil Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 205. Argentina Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 206. Chile Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 207. Colombia Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 208. Peru Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 209. Saudi Arabia Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 210. Israel Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 211. UAE Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 212. Turkey Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 213. Iran Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 214. Egypt Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Table 215. Key Raw Materials Table 216. Raw Materials Key Suppliers Table 217. Typhoid Vaccine Distributors List Table 218. Typhoid Vaccine Customers List Table 219. Research Programs/Design for This Report Table 220. Authors List of This Report Table 221. Secondary Sources Table 222. Primary Sources List of Figures Figure 1. Typhoid Vaccine Image Figure 2. Global Typhoid Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Typhoid Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Type Typhoid Vaccine Image Figure 5. Injection Type Typhoid Vaccine Image Figure 6. Global Typhoid Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Typhoid Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Pharmaceutical & Biotechnology Companies Image Figure 9. Hospital Image Figure 10. Research & Academic Laboratories Image Figure 11. Others Image Figure 12. Global Typhoid Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Typhoid Vaccine Revenue (2021-2032) & (US$ Million) Figure 14. Global Typhoid Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Typhoid Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Typhoid Vaccine Revenue Market Share by Region (2021-2032) Figure 17. Global Typhoid Vaccine Sales (2021-2032) & (K Units) Figure 18. Global Typhoid Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Typhoid Vaccine Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Typhoid Vaccine Sales YoY (2021-2032) & (K Units) Figure 21. Europe Typhoid Vaccine Sales YoY (2021-2032) & (K Units) Figure 22. China Typhoid Vaccine Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Typhoid Vaccine Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Typhoid Vaccine Sales YoY (2021-2032) & (K Units) Figure 25. Global Typhoid Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Typhoid Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Typhoid Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Typhoid Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Typhoid Vaccine Revenue Market Share by Type (2021-2032) Figure 31. Global Typhoid Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Typhoid Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Typhoid Vaccine Sales Market Share by Type (2021-2032) Figure 34. Global Typhoid Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Typhoid Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Typhoid Vaccine Revenue Market Share by Application (2021-2032) Figure 37. Global Typhoid Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Typhoid Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Typhoid Vaccine Sales Market Share by Application (2021-2032) Figure 40. North America Typhoid Vaccine Revenue Share by Type (2021-2032) Figure 41. North America Typhoid Vaccine Sales Share by Type (2021-2032) Figure 42. North America Typhoid Vaccine Revenue Share by Application (2021-2032) Figure 43. North America Typhoid Vaccine Sales Share by Application (2021-2032) Figure 44. North America Typhoid Vaccine Revenue Share by Country (2021-2032) Figure 45. North America Typhoid Vaccine Sales Share by Country (2021-2032) Figure 46. Europe Typhoid Vaccine Revenue Share by Type (2021-2032) Figure 47. Europe Typhoid Vaccine Sales Share by Type (2021-2032) Figure 48. Europe Typhoid Vaccine Revenue Share by Application (2021-2032) Figure 49. Europe Typhoid Vaccine Sales Share by Application (2021-2032) Figure 50. Europe Typhoid Vaccine Revenue Share by Country (2021-2032) Figure 51. Europe Typhoid Vaccine Sales Share by Country (2021-2032) Figure 52. China Typhoid Vaccine Revenue Share by Type (2021-2032) Figure 53. China Typhoid Vaccine Sales Share by Type (2021-2032) Figure 54. China Typhoid Vaccine Revenue Share by Application (2021-2032) Figure 55. China Typhoid Vaccine Sales Share by Application (2021-2032) Figure 56. Asia Typhoid Vaccine Revenue Share by Type (2021-2032) Figure 57. Asia Typhoid Vaccine Sales Share by Type (2021-2032) Figure 58. Asia Typhoid Vaccine Revenue Share by Application (2021-2032) Figure 59. Asia Typhoid Vaccine Sales Share by Application (2021-2032) Figure 60. Asia Typhoid Vaccine Revenue Share by Country (2021-2032) Figure 61. Asia Typhoid Vaccine Sales Share by Country (2021-2032) Figure 62. SAMEA Typhoid Vaccine Revenue Share by Type (2021-2032) Figure 63. SAMEA Typhoid Vaccine Sales Share by Type (2021-2032) Figure 64. SAMEA Typhoid Vaccine Revenue Share by Application (2021-2032) Figure 65. SAMEA Typhoid Vaccine Sales Share by Application (2021-2032) Figure 66. SAMEA Typhoid Vaccine Revenue Share by Country (2021-2032) Figure 67. SAMEA Typhoid Vaccine Sales Share by Country (2021-2032) Figure 68. Typhoid Vaccine Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Typhoid Vaccine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Type Typhoid Vaccine
  • Injection Type Typhoid Vaccine
Applications
  • Pharmaceutical & Biotechnology Companies
  • Hospital
  • Research & Academic Laboratories
  • Others
Companies covered
  • Actiza Pharmaceutical
  • Bharat Biotec
  • Merit Pharmaceuticals
  • PaxVax
  • GlaxoSmithKline
  • Merck
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Typhoid Vaccine Market by Type
  3. 1.2.1 Global Typhoid Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral Type Typhoid Vaccine
  5. 1.2.3 Injection Type Typhoid Vaccine
  6. 1.3 Typhoid Vaccine Market by Application
  7. 1.3.1 Global Typhoid Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Pharmaceutical & Biotechnology Companies
  9. 1.3.3 Hospital
  10. 1.3.4 Research & Academic Laboratories
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Typhoid Vaccine Market Dynamics
  1. 2.1 Typhoid Vaccine Industry Trends
  2. 2.2 Typhoid Vaccine Industry Drivers
  3. 2.3 Typhoid Vaccine Industry Opportunities and Challenges
  4. 2.4 Typhoid Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Typhoid Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Typhoid Vaccine Revenue by Region
  3. 3.2.1 Global Typhoid Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Typhoid Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Typhoid Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Typhoid Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Typhoid Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Typhoid Vaccine Sales by Region
  9. 3.4.1 Global Typhoid Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Typhoid Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Typhoid Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Typhoid Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Typhoid Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Typhoid Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Typhoid Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Typhoid Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Typhoid Vaccine Sales by Manufacturers
  6. 4.2.1 Global Typhoid Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Typhoid Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Typhoid Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Typhoid Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Typhoid Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Typhoid Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Typhoid Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Typhoid Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Typhoid Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Typhoid Vaccine Tier 1, Tier 2, and Tier 3
5 Typhoid Vaccine Market by Type
  1. 5.1 Global Typhoid Vaccine Revenue by Type
  2. 5.1.1 Global Typhoid Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Typhoid Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Typhoid Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Typhoid Vaccine Sales by Type
  6. 5.2.1 Global Typhoid Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Typhoid Vaccine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Typhoid Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Typhoid Vaccine Price by Type
6 Typhoid Vaccine Market by Application
  1. 6.1 Global Typhoid Vaccine Revenue by Application
  2. 6.1.1 Global Typhoid Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Typhoid Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Typhoid Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Typhoid Vaccine Sales by Application
  6. 6.2.1 Global Typhoid Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Typhoid Vaccine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Typhoid Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Typhoid Vaccine Price by Application
7 Company Profiles
  1. 7.1 Actiza Pharmaceutical
  2. 7.1.1 Actiza Pharmaceutical Company Information
  3. 7.1.2 Actiza Pharmaceutical Business Overview
  4. 7.1.3 Actiza Pharmaceutical Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Actiza Pharmaceutical Typhoid Vaccine Product Portfolio
  6. 7.1.5 Actiza Pharmaceutical Recent Developments
  7. 7.2 Bharat Biotec
  8. 7.2.1 Bharat Biotec Company Information
  9. 7.2.2 Bharat Biotec Business Overview
  10. 7.2.3 Bharat Biotec Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bharat Biotec Typhoid Vaccine Product Portfolio
  12. 7.2.5 Bharat Biotec Recent Developments
  13. 7.3 Merit Pharmaceuticals
  14. 7.3.1 Merit Pharmaceuticals Company Information
  15. 7.3.2 Merit Pharmaceuticals Business Overview
  16. 7.3.3 Merit Pharmaceuticals Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merit Pharmaceuticals Typhoid Vaccine Product Portfolio
  18. 7.3.5 Merit Pharmaceuticals Recent Developments
  19. 7.4 PaxVax
  20. 7.4.1 PaxVax Company Information
  21. 7.4.2 PaxVax Business Overview
  22. 7.4.3 PaxVax Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 PaxVax Typhoid Vaccine Product Portfolio
  24. 7.4.5 PaxVax Recent Developments
  25. 7.5 GlaxoSmithKline
  26. 7.5.1 GlaxoSmithKline Company Information
  27. 7.5.2 GlaxoSmithKline Business Overview
  28. 7.5.3 GlaxoSmithKline Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 GlaxoSmithKline Typhoid Vaccine Product Portfolio
  30. 7.5.5 GlaxoSmithKline Recent Developments
  31. 7.6 Merck
  32. 7.6.1 Merck Company Information
  33. 7.6.2 Merck Business Overview
  34. 7.6.3 Merck Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Merck Typhoid Vaccine Product Portfolio
  36. 7.6.5 Merck Recent Developments
  37. 7.7 Sanofi
  38. 7.7.1 Sanofi Company Information
  39. 7.7.2 Sanofi Business Overview
  40. 7.7.3 Sanofi Typhoid Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Sanofi Typhoid Vaccine Product Portfolio
  42. 7.7.5 Sanofi Recent Developments
8 North America
  1. 8.1 North America Typhoid Vaccine Market Size by Type
  2. 8.1.1 North America Typhoid Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Typhoid Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Typhoid Vaccine Price by Type (2021-2032)
  5. 8.2 North America Typhoid Vaccine Market Size by Application
  6. 8.2.1 North America Typhoid Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Typhoid Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Typhoid Vaccine Price by Application (2021-2032)
  9. 8.3 North America Typhoid Vaccine Market Size by Country
  10. 8.3.1 North America Typhoid Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Typhoid Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Typhoid Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Typhoid Vaccine Market Size by Type
  2. 9.1.1 Europe Typhoid Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Typhoid Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Typhoid Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Typhoid Vaccine Market Size by Application
  6. 9.2.1 Europe Typhoid Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Typhoid Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Typhoid Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Typhoid Vaccine Market Size by Country
  10. 9.3.1 Europe Typhoid Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Typhoid Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Typhoid Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Typhoid Vaccine Market Size by Type
  2. 10.1.1 China Typhoid Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Typhoid Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Typhoid Vaccine Price by Type (2021-2032)
  5. 10.2 China Typhoid Vaccine Market Size by Application
  6. 10.2.1 China Typhoid Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Typhoid Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Typhoid Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Typhoid Vaccine Market Size by Type
  2. 11.1.1 Asia Typhoid Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Typhoid Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Typhoid Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Typhoid Vaccine Market Size by Application
  6. 11.2.1 Asia Typhoid Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Typhoid Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Typhoid Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Typhoid Vaccine Market Size by Country
  10. 11.3.1 Asia Typhoid Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Typhoid Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Typhoid Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Typhoid Vaccine Market Size by Type
  2. 12.1.1 SAMEA Typhoid Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Typhoid Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Typhoid Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Typhoid Vaccine Market Size by Application
  6. 12.2.1 SAMEA Typhoid Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Typhoid Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Typhoid Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Typhoid Vaccine Market Size by Country
  10. 12.3.1 SAMEA Typhoid Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Typhoid Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Typhoid Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Typhoid Vaccine Value Chain Analysis
  2. 13.1.1 Typhoid Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Typhoid Vaccine Production Mode & Process
  6. 13.2 Typhoid Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Typhoid Vaccine Distributors
  9. 13.2.3 Typhoid Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst